ASCO 2024 Meeting Report — Lung Cancers
The 2024 American Society of Clinical Oncology (ASCO) annual meeting, held May 30 to June 3 in Chicago, highlighted important advances in treatment
The 2024 American Society of Clinical Oncology (ASCO) annual meeting, held May 30 to June 3 in Chicago, highlighted important advances in treatment
There are numerous challenges with cell and gene therapies in oncology, such as accessibility, cost, and prior authorizations, as well as the need for improved…
Presenters at the American Diabetes Association 84th Scientific Sessions analyzed potential developments in treatment for patients with diabetes and diabetic kidney disease.
Dr. Jaye Hefner talks to Dr. Atul Malhotra about the results of two trials that looked at tirzepatide for the treatment of obstructive sleep apnea…
There are numerous challenges with cell and gene therapies in oncology, such as accessibility, cost, and prior authorizations, as well as the need for improved…
Niki Shah Vice President of Impact Innovation and Activation at McKesson, previews the 2024 McKesson ideaShare conference.
Transfer medicine requires a distinct skill set, quite separate from clinical medicine; complex transfers have much that can go wrong.
With improved technology and innovations for diabetes, it is essential for health care providers and health agencies to collaborate to combat rising rates of diabetes.
Doctors can intervene effectively and safely to combat misinformation on social media, argue Leonard Hofstra and Diederik Gommers Researchers have estimated that vaccine hesitancy may…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
The quadruplet regimen added bortezomib to the current standard of care, which is a triplet regimen of isatuximab, lenalidomide, and dexamethasone for patients with transplant-ineligible,…